ESC Premium Access

Dapagliflozin-induced attenuation of cardiac remodeling in rats with Type 1 diabetes mellitus

Congress Session

About the speaker

Associate Professor Marina Okoshi

Faculty of Medicine of Botucatu, UNESP, Botucatu (Brazil)
0 follower

6 more presentations in this session

Feasibility and efficacy of early donepezil with or without metoprolol in reperfused myocardial infarction rats

Speaker: Doctor M. Li (Osaka, JP)


The best of two worlds: Vascular protection and decongestion without RAAS stimulation mediated by a novel dual acting V1a/V2 vasopressin receptor antagonist

Speaker: Doctor P. Kolkhof (Wuppertal, DE)


Cardioprotective effects of a novel designer C-type natriuretic peptide-based therapeutic, C53 , for the prevention of post-myocardial infarction heart failure

Speaker: Mr Y. Chen (Rochester, US)


Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat

Speaker: Doctor H. Yip (Kaohsiung, TW)


Empagliflozin improves left ventricular diastolic function in db/db mice without altering cardiac expression of enzymes relevant for ketone body or branched chain amino acid catabolism.

Speaker: Miss J. Moellmann (Aachen, DE)


Access the full session

Targeting reverse remodelling in heart failure

Speakers: Associate Professor M. Okoshi, Doctor M. Li, Doctor P. Kolkhof, Mr Y. Chen, Doctor H. Yip...

About the event


ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk